Sleep Apnea Devices Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2025 - 2032)

Sleep Apnea Devices Market merging Trends

Portable and Wearable Sleep Apnea Devices Are Key Trends

• With the evolution of technologically advanced products, there has been a rise in the adoption of portable devices.
• For instance, products with additional features, such as the use of an algorithm and pressure sensor to determine the best pressure, are available in the market.
• Moreover, portable devices are compact and easy to take anywhere, which further adds to the demand for these products.
• Furthermore, the growing usage of oral appliances is also supporting the market growth, since these devices are comparatively economical.
• It has been observed that developed and developing countries are struggling with increasing healthcare costs per capita, which propel the demand for low-cost therapeutic devices.
• In addition, oral appliances are less expensive in comparison to continuous positive airway pressure (CPAP) devices and other surgical procedures required to treat the condition, thereby leading to high demand for such products among the general population.
• Another key trend is wearable sleep trackers that are embedded with the biometric sensor technology.
• These devices monitor the quality of sleep and record and transmit the data corresponding to various physiological conditions of a patient.
• A sleep tracking device is equipped with a pulse oximeter and accelerometer, which allow the user to regularly monitor the heart rate, sleep pattern, and oxygen saturation level in the blood.
• Some of the commercially available devices include the O2 Vibe Fitness & Sleep Monitor manufactured by BodiMetrics LLC and GO2SLEEP by SLEEPON Inc.

Increasing Geriatric Population IS Major Driver for Market

• The increasing geriatric population is also playing a major role in driving the growth of the global market.
• With aging, people suffer from health problems, due to psychological factors and changes in cardiac rhythm, thus making them more susceptible to sleep disorders.
• Moreover, insomnia and OSA are some of the most common sleeping disorders observed in aged people.
• In order to improve the quality of life and ensure a healthy lifestyle among the geriatric population, the demand for such devices is growing rapidly.
• According to the population division of the Department of Economic and Social Affairs (DESA) in the United Nations Secretariat, aged people are expected to make up 30% of the population in China by 2050.
• The population of people aged 60 years and above is expected to reach 1.4 billion by 2030 and 2.1 billion by 2050, globally.

Segmentation Analysis

Insights by Type

Therapeutic devices hold larger share in the market, of 65%, and they are also the faster-growing category. This is due the availability of various therapeutic devices for the treatment of sleep apnea in which sleeping aids are the supporting products for the treatment. This growth is mainly expected to be led by the increasing number of OSA cases, across the globe. PAP devices are the most-commonly prescribed treatment option by the doctors due to its targeted and effective medication benefits over other sleep apnea devices.

These devices are covered:

• Therapeutic Devices (Larger and Faster-Growing Category)
  • Positive airway pressure (PAP) devices
    • Continuous positive air pressure (CPAP) devices
    • Automatic positive air pressure (APAP) devices
    • Bi-level positive air pressure (BPAP) devices
  • Facial interfaces
    • Masks
    • Cushions
  • Oral appliances
  • Adaptive servo-ventilators (ASVs)
  • Others
• Diagnostic Devices
  • Polysomnography devices
  • Respiratory polygraphs
  • Pulse oximeters
  • Actigraphy devices
  • Sleep screening devices
  • Home sleep testing devices
  • Others

Insights by End User

Sleep laboratories and hospitals were the larger category in the global market in 2024. This can be attributed to rise in the prevalence of sleep apnea, and rising awareness among people for the health implications of the disease. While long-term treatment can be done at home, most people still choose hospitals and sleep laboratories because these places employ trained doctors, who guide patients every step of the way. Moreover, an actual diagnosis cannot be done at home; people can only get a vague idea of their condition, but a detailed assessment can only be made by a doctor. Skilled medical professionals are also needed to recommend the exact treatment and the kind of device that will be the most effective.

During the forecast period, the at-home category is expected to observe the faster growth, at a CAGR of 7%. This growth would be characterized by the increasing demand of compact and easy to use sleep apnea devices, that can be used easily by the patients at-home. With the evolution of technologically advanced products, there has been a rise in the adoption of portable devices. For instance, products with additional features, such as the use of an algorithm and pressure sensor to determine the best pressure, are available in the market.

The demand for home sleep monitoring devices is also rising. These devices play an essential role in monitoring a patient’s sleep, either overnight or during the day. The increasing adoption of these devices is ascribed to the fact that these tests are painless and immensely useful in diagnosing sleep disorders, such as insomnia, narcolepsy, and sleep apnea. Moreover, as these devices can be easily used in homecare settings, they help patients study several indicators of sleep apnea, including the oxygen saturation level, oronasal airflow, body position, and respiratory effort. Furthermore, these tests are more cost-effective as compared to those conducted at sleep laboratories, as home sleep apnea testing (HSAT) devices cost between USD 150 and USD 200.

These end users are covered:

• Sleep Laboratories and Hospitals (Larger Category)
• At-Home (Faster-Growing Category)

Sleep Apnea Devices Market Regional Growth Dynamics

Globally, North America leads the market for sleep apnea devices with 45% share in 2024. This can be credited to the snowballing incidence of sleeping disorders. Furthermore, the rise in the occurrence of various health conditions, such as obesity and heart diseases, which are high-risk factors for sleep apnea is also expected to contribute toward the growth of the market.

Moreover, several government bodies are running awareness programs to educate people and medical practitioners about healthy sleeping habits. Moreover, the key players in the market are investing huge capital to develop technologically efficient, effective, and easy-to-use devices.

It has been observed that changes in lifestyle patterns often lead to many sleeping disorders. Moreover, the increasing consumption of tobacco, caffeine, and alcohol also affects the sleep cycle of an individual. Furthermore, the growth in the number of sleep care centers in the region is expected to boost the growth of the market.

As North America has several sleep centers, such as Carilion Clinic, Adam Moscovitch, Florida Lung, Asthma and Sleep Specialists, Oregon Sleep Associates, and Sound Sleep Health, will further drive the growth in the region.

Globally, APAC is the fastest growing region, with 8% CAGR, owing to the growing prevalence of OSA and changes in diet and lifestyle patterns. According to a study funded by the JurongHealth Services Research and Quality Improvement Grant, one in three Singaporeans have moderate-to-severe OSA and up to one in 10 Singaporeans suffer from severe apnea. The study also found that the Chinese and Malays observed high rates of OSA in comparison to Indians.

Furthermore, the region is also witnessing a significant rise in unhealthy lifestyle patterns among the younger population, such as staying up late and interrupting sleep due to work pressure. Moreover, the growing elderly population in the region is more susceptible to apnea, due to multiple comorbid diseases, which will drive the demand for therapeutic and diagnostic devices.

Additionally, the growing number of undiagnosed apnea patients or those who face delayed diagnosis, due to the lack of awareness in the region is a health concern. The Neurology and Sleep Centre undertook a campaign to spread awareness about the harmful effects of sleep disorders within India.

The regions and countries analyzed for this report include:

• North America (Largest Regional Market)
  • U.S. (Larger Country Market)
  • Canada (Faster-Growing Country Market)
• Europe
  • Germany (Largest Country Market)
  • U.K.
  • France
  • Italy
  • Spain (Fastest-Growing Country Market)
  • Rest of Europe
• Asia-Pacific (APAC) (Fastest-Growing Regional Market)
  • China (Largest Country Market)
  • Japan
  • India (Fastest-Growing Country Market)
  • South Korea
  • Australia
  • Rest of APAC
• Latin America (LATAM)
  • Brazil (Largest Country Market)
  • Mexico (Fastest-Growing Country Market)
  • Rest of LATAM
• Middle East and Africa (MEA)
  • Saudi Arabia (Largest Country Market)
  • South Africa
  • U.A.E. (Fastest-Growing Country Market)
  • Rest of MEA

Sleep Apnea Devices Market Competitive Landscape

• The global sleep apnea devices market is fragmented in nature, due to the presence of several giant and small- and medium-sized players.
• These companies offer varied devices to diagnose and treat sleep apnea.
• Moreover, the significant presence of the home-use customer base fragments the market by allowing even smaller companies to make appreciable sales.
• The easy access to online channels to target at-home consumers is another factor that increases the concentration of players.
• While the well-known medical device companies generally cater more to hospitals, clinics, and sleep centers, the smaller companies generate a lot of revenue from product sales to individual customers.
• These players in the sleep apnea devices market are engaged in strategic developments, such as product launches, mergers & acquisitions, and partnerships, to maintain their edge over competitors.

Sleep Apnea Devices Market Developments

• In December 2024, Nyxoah SA announced that OSA treatment with its Genio neurostimulator had begun for the first batch of patients at University College London Hospitals NHS Foundation Trust. The device, which is free from leads and a battery, is implantable with a single incision. It stimulates the nerves to keep OSA patients’ airway open, allowing them to breathe normally during sleep.
• In October 2024, Amazon.com Inc. filed a patent for a smart pillow that uses an audio input device to record and assess the sounds people make and sensors to track bodily movements while they sleep. Once it confirms an adverse sleep event, the pillow changes its shape by inflating or deflating to position patients’ heads in a way that lets them breathe normally.
• In September 2024, Apple Inc. launched a sleep monitor in Apple Watch, which uses the company’s Breathing Disturbances metric to assess breathing patterns every 30 years and notify users upon detecting moderate-to-severe sleep apnea. This feature utilizes the Apple Watch’s accelerometer sensor to detect the movement of the wrist, which is common when normal breathing is disrupted during sleep. Upon approval from the FDA, the feature was expected to be launched in over 150 countries.
• In August 2024, Oxymed launched its SleepEasy automated CPAP therapy devices in India. They are equipped with a hose pipe, humidifier, power adapter, nasal mask, filter, and a USB drive for data retrieval.